Levothyroxine recalls: lots, NDC and companies
16 FDA recall records mention Levothyroxine since December 11, 2024. Each covers specific lots from one company. Check yours below.
Check your Levothyroxine bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Pfizer: Levoxyl and 1 more
Hazard (FDA): Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
FDAMedicines
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 11 more
Hazard (FDA): Subpotent Drug
FDAMedicines
Major Pharmaceuticals: Levothyroxine Sodium Tablets and 11 more
Hazard (FDA): Subpotent Drug
FDAMedicines
MACLEODS PHARMA USA, INC: Levothyroxine Sodium Tablets USP 150 mcg
Hazard (FDA): Subpotent Drug
FDAMedicines
Alvogen, Inc: Levothyroxine Sodium Tablets
Hazard (FDA): Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
FDAMedicines
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets
Hazard (FDA): Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
FDAMedicines
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 6 more
Hazard (FDA): Subpotent Drug: Assay below the approved specification
FDAMedicines
Macleods Pharmaceuticals Ltd: Levothyroxine Sodium Tablets
Hazard (FDA): Presence of a foreign substance: black hair found embedded in tablet.
FDAMedicines
Potency
Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 1 more
Hazard (FDA): Super-Potent Drug: Out of specification potency results were obtained.
FDAMedicines
Lupin Pharmaceuticals Inc.: Levothyroxine Sodium Tablets
Hazard (FDA): Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
FDAMedicines
Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 5 more
Hazard (FDA): Subpotent and Superpotent Drug
FDAMedicines
Potency
Viatris Inc: Levothyroxine Sodium Tablets USP and 10 more
Hazard (FDA): Superpotent Drug and Subpotent Drug: potency failures obtained
FDAMedicines